Immunotherapy in Lung Cancer | Anne S Tsao, MD, MBA

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer — Faculty Presentation 2: Relevant Advances in the Care of Patients with Non-Metastatic NSCLC, Small Cell Lung Cancer (SCLC) and Mesothelioma – Dr Anne Tsao CME information and select publications